FDA approves Retatrutide this year?
Smart Money Analysis
16 top-performing wallets have taken positions on this market, with an overwhelming 81% consensus betting NO. This creates a significant 20.5% edge between the smart money consensus and the current market price of $0.78. Total tracked exposure from smart wallets stands at $55.5K.
Opportunity Metrics
Score: 11Alpha Signal: BUY_NO
16 smart wallets • STRONG_NO consensus (81%)
Market Stats
Key Questions
What are the current Polymarket odds on "FDA approves Retatrutide this year?"?▾
As of the latest data, YES is trading at $0.23 (22.5% implied probability) and NO is trading at $0.78 (77.5% implied probability). The market has $543K in 24-hour trading volume.
What is smart money betting on "FDA approves Retatrutide this year?"?▾
16 tracked smart wallets are positioned on this market with a 81% consensus betting NO. These wallets have a combined exposure of $55.5K. The alpha score is 18 out of 100.
What is the alpha score for this market?▾
This market has an alpha score of 18 out of 100, which indicates moderate tracking interest. The alpha score measures the concentration and conviction of high-performing wallets positioned in this market.
How can I trade this market?▾
You can trade this market directly through Polymarket, or use PolyFire's Telegram bot for instant execution with copy trading, AI signals, and smart wallet tracking. PolyFire charges a 1% fee on trades only and is fully non-custodial.
What does the consensus edge mean?▾
The 20.5% consensus edge represents the gap between what smart money is paying and where the market currently trades. A larger edge suggests smart wallets see value that the broader market hasn't priced in yet.